FDA Inspection 713382 - Newark Beth Israel Medical Center - Blood Bank - March 21, 2011

FDA Inspection 713382 for Newark Beth Israel Medical Center - Blood Bank on March 21, 2011. Classification: Voluntary Action Indicated (VAI).

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA Inspection 713382 for Newark Beth Israel Medical Center - Blood Bank on March 21, 2011. Classification: Voluntary Action Indicated (VAI).

Violation Codes

21 CFR 606.100(b)

21 CFR 606.160(b)

21 CFR 606.60(a)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Newark Beth Israel Medical Center - Blood Bank

Inspection Date

March 21, 2011

Product Type

Biologics

Office

Center for Biologics Evaluation and Research

ID: f655788f-0ecb-4ba3-bcfd-e282059c07cd

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox